CEO Brille's large open-market sale after a derivative exercise is a strong negative signal, especially with no insider buying to offset it. Monitor for any upcoming earnings miss, guidance cut, or material adverse news that may have prompted the selling.
Price Chart
Executive Summary
Two Caris Life Sciences insiders, including CEO Brian Brille, sold a total of $12.37M in shares within a week. Brille's $12.13M open-market sale followed a derivative exercise at a fraction of the market price, netting a large cash gain. The selling is material relative to the company's market cap and is not offset by any insider buying.
Key Financial Metrics
Key Facts
- CEO Brian Brille sold 400,000 shares for $12.13M on 2026-09-17 at $30.33/share
- Brille's sale followed exercise of derivatives at $2.44/share, realizing a large gain
- Director John Russel Denton sold 7,500 shares for $239K on 2026-09-22 at $31.82/share
- Total insider sales of $12.37M in a 7-day window with zero insider purchases
- No 10b5-1 plan indicated for either sale
Financial Impact
Total insider sales of $12.37M represent approximately 3.8% of the company's $326M market cap, a highly material proportion
Risk Factors
- CEO selling a large stake may signal deteriorating business fundamentals or upcoming bad news
- No insider buying suggests management lacks confidence in near-term prospects
- The derivative exercise at $2.44 followed by immediate sale at $30.33 indicates profit-taking rather than conviction
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-CAI-1790197641893 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | Institutional Cluster | $32.35 | awaiting T+20 | — | $32.50 (+0.46%) |
Oct 15, 2026 12d ago | Press Release | $31.76 | awaiting T+20 | — | $32.50 (+2.33%) |
Sep 23, 2026 4w ago | Insider Cluster | $32.27 $31.71 | ▲ +1.74% | ▲ +1.32% | $32.50 (−0.71%) |
Sep 14, 2026 6w ago | 8-K | $28.50 $29.53 | ▲ +3.61% | ▲ +0.89% | $32.50 (+14.04%) |
Aug 7, 2026 11w ago | 144 | $23.40 $24.82 | ▼ −6.07% | ▼ −6.98% | $32.50 (−38.89%) |
Jul 13, 2026 15w ago | Insider Cluster | $17.06 $23.40 | ▲ +37.16% | ▲ +33.98% | $32.50 (+90.50%) |
Jun 11, 2026 19w ago | Institutional Cluster | $18.00 $17.87 | ▼ −0.72% | ▼ −2.61% | $32.50 (+80.56%) |
Apr 23, 2026 26w ago | DEFA14A | $19.79 $15.70 | ▼ −20.67% | ▼ −25.30% | $32.50 (+64.22%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers